MYC and BCL2 genetic alterations are associated with COO subtype-specific clinical impact in R-CHOP treated DLBCL.
Home / Resource Library / Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell of origin-specific clinical impact